These findings suggest that GC-A activates cardiac RGS4, which then inhibits the activity of Gαq and its downstream hypertrophic effectors, thereby playing a key role in the GC-A-mediated inhibition of cardiac hypertrophy. The gene discussed is GCA; the disease is cardiac hypertrophy.